Candel Therapeutics shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Candel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Candel Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Candel Therapeutics by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $617k | 121k | 5.10 |
| 2025-06-30 | $576k | 114k | 5.06 |
| 2025-03-31 | $474k | 84k | 5.65 |
| 2024-12-31 | $453k | 52k | 8.68 |
| 2024-09-30 | $324k | 47k | 6.93 |
| 2024-06-30 | $290k | 47k | 6.20 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management